Skip to main contentSkip to navigation
Sirius Investors
Haemonetics Corporation

Haemonetics Corporation

HAE
NYSEHealthcare

Revenue Analysis - HAE

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

HAE Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Hospital Products and Services

0.0% of total revenue

$299.3M

Plasma Products and Services

0.0% of total revenue

$130.3M

Blood Center Products and Services

0.0% of total revenue

$108.3M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Blood Center Products and Services
Hospital Products and Services
Plasma Products and Services
3/28/2026$108.3M$299.3M$130.3M
12/27/2025$113.1M$287.0M$138.9M
9/27/2025$112.9M$291.0M$125.4M
6/28/2025$51.8M$139.7M$129.9M
3/29/2025$54.8M$147.2M$126.4M
12/28/2024$70.3M$144.0M$134.2M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Stable Segments
Hospital Products and Services+4.3%
Plasma Products and Services-6.2%
Blood Center Products and Services-4.3%

Earnings Reports

Want to see how HAE's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports